Author: healthadmin

Pfizer and Alvinas have found a buyer for their newly approved breast cancer drug Vepanu, selling an exclusive worldwide license to Rigel Pharmaceuticals for $85 million upfront, with potentially hundreds of millions of dollars more in milestone and royalty payments. The agreement includes an initial upfront payment of $70 million and an additional $15 million upon completion of certain “development and manufacturing transition activities.” All payments to Rigel, including up to $320 million in future development, regulatory and commercial milestone payments, plus tiered royalties, will be split equally between Alvinas and Pfizer. Rigel, a South San Francisco-based company that sells…

Since Roche launched Babismo, a long-acting eye disease treatment, in 2022, Bayer and Regeneron have hit sales of competing treatments Eylea, further hurting the U.S. biotech. Bayer has been able to keep Eyrie’s annual sales relatively stable, as they have hovered between 3.1 billion euros and 3.3 billion euros over the past four years, respectively. But biosimilar competition is hitting German companies with all their might as the year draws to a close. In the first quarter (PDF), Bayer’s Eylea sales were 623 million euros ($731 million), down 24% year over year. It was also down 11% quarter over quarter.…

Scientists have discovered a molecular “switch” in mice that turns on an energy-burning system hidden inside brown fat. This discovery could ultimately help researchers develop new treatments for bone diseases. The survey results are natureprovides new insights into how brown fat functions. Unlike white fat, which stores energy, brown fat burns calories and produces heat. Scientists have long believed that this heat production relies on a single biological pathway. But in recent years, researchers have identified a second pathway that functions in parallel to the original, but it was unclear what activates it. A team led by Lawrence Kazak of…

SkillCare, a manufacturer of specialty healthcare products, on Tuesday announced the launch of the SkillCare Clinical Innovation Partnership (SCIP). The program is designed to help healthcare providers commercialize cutting-edge clinical needs and ideas. The program allows clinicians and organizations to work with the New Rochelle, New York-based company to develop products by identifying needs, refining concepts, and evaluating feasibility. Skill-Care CEO Jonathan Treiber told Fierce Healthcare that the program has been “nearly 50 years in the making.” “Skillcare has been around for nearly 50 years,” Treiber said. “And my father-in-law, who started the company, always felt that developing products in…

“Infancy,” Dr. Oz said, is the name of a disease that affects one in three Americans. I think excess babies means having too many children, so what do you call having the right number of children? Baby-neutral? A balanced baby? Send us your news tips and favorite lines from raise arizona to (email protected) Or Signal’s John_Wilkerson.07. Battle for exemption from labor requirements Patient groups are fighting to be exempted from Medicaid’s work requirements, but states’ unusually fast implementation timelines pose a headache. Advocates for Medicaid recipients want the federal government to exempt certain patient populations from new requirements that…

Researchers at the University of Missouri are developing a new method to remove microscopic plastic pollutants from water using specially engineered algae. Mizzou researcher Susie Dai recently created an engineered algae strain designed to capture harmful microplastics from contaminated water. In addition to cleaning waterways, her long-term goal is to recycle the plastic she collects into safer bioplastic materials, such as composite plastic films. “Microplastics are pollutants found almost everywhere in the environment, including ponds, lakes, rivers, sewage, and the fish we consume,” said Dai, a professor of engineering and principal investigator at the Bond Life Science Center. “Currently, most…

A study comparing psychedelic enthusiasts and the general public (those who have had psychedelic experiences) found that enthusiasts tended to report a much greater positive effect on their quality of life. Enthusiasts also showed higher levels of directness, extraversion, and agreeableness. This indicates that recruitment strategies focused on including enthusiasts in psychedelic research can shape the outcomes obtained in the research. The paper was published in. Psychotropic Drugs Journal. Psychedelic drugs are substances that can significantly alter perception, mood, thinking, and sense of self. These can change the way people experience colors, sounds, time, memories, emotions, and the meaning of…

Older people who cut back on fat in their diets and reduced their intake of animal protein showed signs of becoming biologically younger, according to new research from the University of Sydney. This research aged cellsfound that adults between the ages of 65 and 75 experienced a decrease in their estimated “biological age” after following a specific diet for just four weeks. Researchers say the findings suggest that changing your diet later in life can quickly improve markers associated with aging and overall health. The research was led by Dr Caitlin Andrews from the School of Life and Environmental Sciences…

With positive momentum building on plans for the second half of 2025, European Union legislators have taken an important step towards introducing a new regional framework focused on expanding supplies of critical medicines and resolving potential drug shortages. According to an announcement on May 12, the Council of the European Union and the European Parliament have reached a tentative agreement on this regulation, allowing the European Union to move forward with its proposed Critical Medicines Act (CMA). The framework, which still needs to be finalized and formally approved by the EU Council and Parliament, was introduced last March to avoid…

Virtual care and health navigation company Included Health has launched a new artificial intelligence-powered tool aimed at helping members find care within its network. Provider Connect uses a proprietary matching engine to recommend the best provider for each user, including quality score descriptions. The integrated platform built into its AI assistant is built on “tens of billions” of clinical and cost point data from millions of patients and uses more than 300 specialty-specific quality measures, the company said. “With this release, we’re making it much easier to leverage the power of AI to highlight some of these features and make…